Weiwei Zhou

2.4k total citations · 1 hit paper
63 papers, 1.3k citations indexed

About

Weiwei Zhou is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Weiwei Zhou has authored 63 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 23 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Weiwei Zhou's work include Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (11 papers) and MicroRNA in disease regulation (9 papers). Weiwei Zhou is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (11 papers) and MicroRNA in disease regulation (9 papers). Weiwei Zhou collaborates with scholars based in China, United States and Hong Kong. Weiwei Zhou's co-authors include Yongsheng Li, Juan Xu, Xia Li, Junyi Li, Tiantongfei Jiang, Jiaqi Yin, Liuxin Chen, Qi Wang, Xiaoyan Jin and Yunpeng Zhang and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Nature Communications.

In The Last Decade

Weiwei Zhou

61 papers receiving 1.3k citations

Hit Papers

Pan-cancer characterization of immune-related lncRNAs ide... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiwei Zhou China 19 845 590 197 168 164 63 1.3k
Jing Gong China 22 1.2k 1.4× 787 1.3× 114 0.6× 104 0.6× 222 1.4× 63 1.8k
Alina‐Andreea Zimța Romania 21 947 1.1× 590 1.0× 85 0.4× 153 0.9× 100 0.6× 39 1.4k
Yunhui Li China 21 790 0.9× 556 0.9× 74 0.4× 127 0.8× 66 0.4× 56 1.4k
Di Liu China 22 695 0.8× 347 0.6× 297 1.5× 140 0.8× 83 0.5× 70 1.3k
Guihua Wang China 24 929 1.1× 594 1.0× 116 0.6× 300 1.8× 159 1.0× 95 1.6k
Blanca Ortíz-Quintero Mexico 18 415 0.5× 310 0.5× 266 1.4× 94 0.6× 117 0.7× 38 823
Xiaoyu Fu China 21 817 1.0× 587 1.0× 64 0.3× 161 1.0× 78 0.5× 87 1.4k
Shenshen Wu China 24 886 1.0× 618 1.0× 133 0.7× 207 1.2× 151 0.9× 50 1.6k
Kun Chang China 24 821 1.0× 216 0.4× 332 1.7× 208 1.2× 131 0.8× 61 1.4k
Siyi Zhang China 19 515 0.6× 258 0.4× 91 0.5× 122 0.7× 154 0.9× 57 1000

Countries citing papers authored by Weiwei Zhou

Since Specialization
Citations

This map shows the geographic impact of Weiwei Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Zhou more than expected).

Fields of papers citing papers by Weiwei Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Zhou. The network helps show where Weiwei Zhou may publish in the future.

Co-authorship network of co-authors of Weiwei Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Zhou. A scholar is included among the top collaborators of Weiwei Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Zhou. Weiwei Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Weiwei, Jingyi Shi, Yueying Gao, et al.. (2025). SMTdb: A Comprehensive Spatial Meta-Transcriptome Resource in Cancer. Molecular Biology and Evolution. 42(11).
3.
Liu, Renfeng, An Pei, Wei‐Hsiang Huang, et al.. (2025). Low-Voltage Electrooxidation of Benzyl Alcohol to Benzoic Acid Enhanced by PtZn-ZnOx Interface. Journal of the American Chemical Society. 147(12). 10339–10348. 8 indexed citations
4.
Zhou, Weiwei, Tiantongfei Jiang, Yingying Ma, et al.. (2024). Cancer Stemness Online: A Resource for Investigating Cancer Stemness and Associations with Immune Response. Genomics Proteomics & Bioinformatics. 22(4). 1 indexed citations
5.
Zhang, Bei, et al.. (2024). Radiometric calibration method for deep convective clouds in the reflective bands of FY-4A/AGRI. National Remote Sensing Bulletin. 29(7). 2345–2355. 1 indexed citations
6.
Huang, Yuxin, Weiwei Zhou, Huiquan Wu, et al.. (2024). Exosomal PSM-E inhibits macrophage M2 polarization to suppress prostate cancer metastasis through the RACK1 signaling axis. Biomarker Research. 12(1). 138–138. 3 indexed citations
7.
Zhou, Weiwei, Jinling Li, Kaiyuan Cao, et al.. (2024). Elevated expression of LCN13 through FXR activation ameliorates hepatocellular lipid accumulation and inflammation. International Immunopharmacology. 131. 111812–111812. 1 indexed citations
9.
Liu, Yujie, et al.. (2024). CanCellVar: A database for single-cell variants map in human cancer. The American Journal of Human Genetics. 111(7). 1420–1430. 3 indexed citations
10.
Gao, Wei, Wei Xu, Jie‐Qiong Jin, et al.. (2023). Impacts of climate change on herpetofauna diversity in the Qinghai‐Tibetan Plateau. Conservation Biology. 37(6). e14155–e14155. 8 indexed citations
11.
Yu, Lei, et al.. (2023). FOXO3-Activated HOTTIP Sequesters miR-615-3p away from COL2A1 to Mitigate Intervertebral Disc Degeneration. American Journal Of Pathology. 194(2). 280–295. 4 indexed citations
12.
Zhou, Weiwei, Yuxin Zhang, Yuanyuan Hu, et al.. (2023). Advances for anti-inflammatory ingredients and activities of Fuzi (lateral root of Aconitum carmichaelii Debx.). International Journal of Food Properties. 27(1). 53–70. 1 indexed citations
13.
Pan, Tao, Gang Xu, Yueying Gao, et al.. (2023). Deep immunophenotyping reveals clinically distinct cellular states and ecosystems in large-scale colorectal cancer. Communications Biology. 6(1). 785–785. 4 indexed citations
14.
Zhou, Weiwei, Tiantongfei Jiang, Kang Xu, et al.. (2023). SORC: an integrated spatial omics resource in cancer. Nucleic Acids Research. 52(D1). D1429–D1437. 18 indexed citations
16.
Zhou, Weiwei, Tao Pan, Jingyi Shi, et al.. (2023). Single-cell RNA binding protein regulatory network analyses reveal oncogenic HNRNPK-MYC signalling pathway in cancer. Communications Biology. 6(1). 82–82. 10 indexed citations
17.
Zhang, Chunlong, Xue Zhang, Kang Xu, et al.. (2023). Prioritizing exhausted T cell marker genes highlights immune subtypes in pan-cancer. iScience. 26(4). 106484–106484. 6 indexed citations
18.
Jiang, Tiantongfei, Weiwei Zhou, Jiaxin Yu, et al.. (2022). ImmCluster: an ensemble resource for immunology cell type clustering and annotations in normal and cancerous tissues. Nucleic Acids Research. 51(D1). D1325–D1332. 9 indexed citations
19.
Su, Min‐Ying, Tao Pan, Weiwei Zhou, et al.. (2022). Data analysis guidelines for single-cell RNA-seq in biomedical studies and clinical applications. Military Medical Research. 9(1). 68–68. 48 indexed citations
20.
Li, Junyi, Tao Pan, Liuxin Chen, et al.. (2021). Alternative splicing perturbation landscape identifies RNA binding proteins as potential therapeutic targets in cancer. Molecular Therapy — Nucleic Acids. 24. 792–806. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026